GEM portfolio company, Events.com to list on the New York Stock Exchange under the ticker RSVP - About Events.com Events.com powers a two-sided marketplace and platform that helps passionate individuals create, promote, discover, and enjoy events. Events.com's platform helps event organizers seamlessly execute their events and allows event goers to discover, interact, and transact with the events they love. The Company offers a robust ecosystem that supports millions of event creators worldwide, catering to various interests. From the prestigious All-In Summit, the world's leading podcast for business, technology, and investing, to the vibrant 100,000-person Renaissance Festival in Florida, the exclusive Club Getaway featured on Bravo, the event calendar on NewYork.com, the transformative Archangel Summit, and movie experiences at the iconic Mayfair Theatre in Ottawa—Events.com technology is the driving force behind unforgettable moments worldwide.
关于我们
Global Emerging Markets ("GEM") was founded in 1991. Our firm is a $3.4 billion alternative investment group that manages a diverse set of investment vehicles focused on emerging markets across the world. The partners have a century of collective experience and as a group have invested in 265 companies across 55 countries. GEM's investment vehicles provide the group and its investors with a diversified portfolio of asset classes that span the global private investing spectrum.
- 网站
-
https://www.gemny.com
The Global Emerging Markets Group (GEM)的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 11-50 人
- 总部
- New York
- 类型
- 私人持股
地点
-
主要
US,New York
The Global Emerging Markets Group (GEM)员工
动态
-
GEM Portfolio Company, FibroBiologics completes Direct Listing on NASDAQ - About FibroBiologics Based in Houston, FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 150+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy. For more information, visit www.FibroBiologics.com.
See coverage of FibroBiologics' direct listing in Seeking Alpha by Val Kennedy. ? #FBLG Read the article here: https://lnkd.in/eYePqBEG
FibroBiologics goes public through direct listing on Nasdaq (NASDAQ:FBLG)
seekingalpha.com
-
GEM Portfolio Company, GRIID to Begin Trading on Nasdaq Global Market Under Ticker “GRDI” - About GRIID Infrastructure Inc. GRIID is a purpose-built bitcoin mining company, founded in 2018, that has operated mining facilities since 2019. GRIID has built long-term power relationships securing affordable, reliable, environmentally responsible power, enabling a vertically integrated self-mining business model with significant growth opportunity. Headquartered in Cincinnati, Ohio, GRIID operates a R&D center in Austin, Texas and a development, deployment and equipment repair center in Rutledge, Tennessee. GRIID currently maintains mining facilities in Watertown, New York; Limestone, Maynardville and Lenoir City, Tennessee. To learn more, please visit?www.griid.com.
GRIID to Begin Trading on Nasdaq Global Market Under Ticker “GRDI”
globenewswire.com
-
GEM Portfolio Company, FibroBiologics to go Public Through Direct Listing on Nasdaq - About FibroBiologics Based in Houston, Texas, FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells. Currently, FibroBiologics holds 150+ U.S. and International issued patents/patents pending across a variety of clinical pathways, including Disc Degeneration, Orthopedics, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.?Visit www.FibroBiologics.com
Biopharma Company FibroBiologics to go Public Through Direct Listing on Nasdaq
https://news.spacconference.com